These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

750 related items for PubMed ID: 10966209

  • 1. Erythrocyte sedimentation rate and C-reactive protein in the evaluation of disease activity and severity in polymyalgia rheumatica: a prospective follow-up study.
    Cantini F, Salvarani C, Olivieri I, Macchioni L, Ranzi A, Niccoli L, Padula A, Boiardi L.
    Semin Arthritis Rheum; 2000 Aug; 30(1):17-24. PubMed ID: 10966209
    [Abstract] [Full Text] [Related]

  • 2. Acute-phase reactants and the risk of relapse/recurrence in polymyalgia rheumatica: a prospective followup study.
    Salvarani C, Cantini F, Niccoli L, Macchioni P, Consonni D, Bajocchi G, Vinceti M, Catanoso MG, Pulsatelli L, Meliconi R, Boiardi L.
    Arthritis Rheum; 2005 Feb 15; 53(1):33-8. PubMed ID: 15696567
    [Abstract] [Full Text] [Related]

  • 3. Circulating CD8+ T cells in polymyalgia rheumatica and giant cell arteritis: a review.
    Martinez-Taboada VM, Blanco R, Fito C, Pacheco MJ, Delgado-Rodriguez M, Rodriguez-Valverde V.
    Semin Arthritis Rheum; 2001 Feb 15; 30(4):257-71. PubMed ID: 11182026
    [Abstract] [Full Text] [Related]

  • 4. Treatment of refractory polymyalgia rheumatica with infliximab: a pilot study.
    Salvarani C, Cantini F, Niccoli L, Catanoso MG, Macchioni P, Pulsatelli L, Padula A, Olivieri I, Boiardi L.
    J Rheumatol; 2003 Apr 15; 30(4):760-3. PubMed ID: 12672196
    [Abstract] [Full Text] [Related]

  • 5. Polymyalgia rheumatica with low erythrocyte sedimentation rate at diagnosis.
    Proven A, Gabriel SE, O'Fallon WM, Hunder GG.
    J Rheumatol; 1999 Jun 15; 26(6):1333-7. PubMed ID: 10381052
    [Abstract] [Full Text] [Related]

  • 6. Age adjustment corrects for apparent differences in erythrocyte sedimentation rate and C-reactive protein values at the onset of seropositive rheumatoid arthritis in younger and older patients.
    Ranganath VK, Elashoff DA, Khanna D, Park G, Peter JB, Paulus HE, Western consortium of practicing rhuemotologists.
    J Rheumatol; 2005 Jun 15; 32(6):1040-2. PubMed ID: 15940764
    [Abstract] [Full Text] [Related]

  • 7. Relationship between interleukin 6 promoter polymorphism at position -174, IL-6 serum levels, and the risk of relapse/recurrence in polymyalgia rheumatica.
    Boiardi L, Casali B, Farnetti E, Pipitone N, Nicoli D, Cantini F, Macchioni P, Bajocchi G, Catanoso MG, Pulsatelli L, Consonni D, Salvarani C.
    J Rheumatol; 2006 Apr 15; 33(4):703-8. PubMed ID: 16583473
    [Abstract] [Full Text] [Related]

  • 8. Relative value of erythrocyte sedimentation rate and C-reactive protein in assessment of disease activity in ankylosing spondylitis.
    Spoorenberg A, van der Heijde D, de Klerk E, Dougados M, de Vlam K, Mielants H, van der Tempel H, van der Linden S.
    J Rheumatol; 1999 Apr 15; 26(4):980-4. PubMed ID: 10229432
    [Abstract] [Full Text] [Related]

  • 9. Intercellular adhesion molecule 1 gene polymorphisms in polymyalgia rheumatica/giant cell arteritis: association with disease risk and severity.
    Salvarani C, Casali B, Boiardi L, Ranzi A, Macchioni P, Nicoli D, Farnetti E, Brini M, Portioli I.
    J Rheumatol; 2000 May 15; 27(5):1215-21. PubMed ID: 10813290
    [Abstract] [Full Text] [Related]

  • 10. Soluble interleukin 2 receptors in polymyalgia rheumatica/giant cell arteritis. Clinical and laboratory correlations.
    Salvarani C, Macchioni P, Boiardi L, Rossi F, Casadei Maldini M, Mancini R, Beltrandi E, Spacca C, Lodi L, Portioli I.
    J Rheumatol; 1992 Jul 15; 19(7):1100-6. PubMed ID: 1512765
    [Abstract] [Full Text] [Related]

  • 11. A disease activity score for polymyalgia rheumatica.
    Leeb BF, Bird HA.
    Ann Rheum Dis; 2004 Oct 15; 63(10):1279-83. PubMed ID: 15361387
    [Abstract] [Full Text] [Related]

  • 12. Equivalence of the acute phase reactants C-reactive protein, plasma viscosity, and Westergren erythrocyte sedimentation rate when used to calculate American College of Rheumatology 20% improvement criteria or the Disease Activity Score in patients with early rheumatoid arthritis. Western Consortium of Practicing Rheumatologists.
    Paulus HE, Ramos B, Wong WK, Ahmed A, Bulpitt K, Park G, Sterz M, Clements P.
    J Rheumatol; 1999 Nov 15; 26(11):2324-31. PubMed ID: 10555885
    [Abstract] [Full Text] [Related]

  • 13. Prevalence of a normal C-reactive protein with an elevated erythrocyte sedimentation rate in biopsy-proven giant cell arteritis.
    Parikh M, Miller NR, Lee AG, Savino PJ, Vacarezza MN, Cornblath W, Eggenberger E, Antonio-Santos A, Golnik K, Kardon R, Wall M.
    Ophthalmology; 2006 Oct 15; 113(10):1842-5. PubMed ID: 16884778
    [Abstract] [Full Text] [Related]

  • 14. Relapse in a population based cohort of patients with polymyalgia rheumatica.
    Kremers HM, Reinalda MS, Crowson CS, Zinsmeister AR, Hunder GG, Gabriel SE.
    J Rheumatol; 2005 Jan 15; 32(1):65-73. PubMed ID: 15630727
    [Abstract] [Full Text] [Related]

  • 15. Validity of the polymyalgia rheumatica activity score in primary care practice.
    Binard A, Lefebvre B, De Bandt M, Berthelot JM, Saraux A, Club "Rhumatismes et Inflammation".
    Ann Rheum Dis; 2009 Apr 15; 68(4):541-5. PubMed ID: 18477738
    [Abstract] [Full Text] [Related]

  • 16. Comparative usefulness of C-reactive protein and erythrocyte sedimentation rate in patients with rheumatoid arthritis.
    Wolfe F.
    J Rheumatol; 1997 Aug 15; 24(8):1477-85. PubMed ID: 9263138
    [Abstract] [Full Text] [Related]

  • 17. The spectrum of polymyalgia rheumatica in northwestern Spain: incidence and analysis of variables associated with relapse in a 10 year study.
    González-Gay MA, García-Porrúa C, Vázquez-Caruncho M, Dababneh A, Hajeer A, Ollier WE.
    J Rheumatol; 1999 Jun 15; 26(6):1326-32. PubMed ID: 10381051
    [Abstract] [Full Text] [Related]

  • 18. Peripheral musculoskeletal manifestations in polymyalgia rheumatica.
    Ceccato F, Roverano SG, Papasidero S, Barrionuevo A, Rillo OL, Paira SO.
    J Clin Rheumatol; 2006 Aug 15; 12(4):167-71. PubMed ID: 16891918
    [Abstract] [Full Text] [Related]

  • 19. Plasma fibrinogen is an accurate marker of disease activity in patients with polymyalgia rheumatica.
    McCarthy EM, MacMullan PA, Al-Mudhaffer S, Madigan A, Donnelly S, McCarthy CJ, Molloy ES, Kenny D, McCarthy GM.
    Rheumatology (Oxford); 2013 Mar 15; 52(3):465-71. PubMed ID: 23125391
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.